The Vanguard Group, Inc. recently announced the acquisition of new stake in National HealthCare Corporation (AMEX:NHC). The institutional investor has increased its shareholding in the Healthcare company by 1.83% to 1.39 million shares with purchase of 24985.0 shares. This fresh investment now brings its stake to 9.06% valued currently at $82.72 million. In addition, Dimensional Fund Advisors LP raised its holdings by 25003.0 to 0.82 million shares. And SSgA Funds Management, Inc. has lifted its position by 1.58% or 5317.0 shares – to 0.34 million shares.
With over 77257.0 National HealthCare Corporation (NHC) shares trading Tuesday and a closing price of $58.26 on the day, the dollar volume was approximately $4.5 million. The shares have shown a negative half year performance of -16.77% and its price on 01/24/23 lost nearly -0.75%. Currently, there are 15.45M common shares owned by the public and among those 12.38M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 1 analysts who have offered their price forecasts for NHC have a consensus price objective of $47.00. The analysts have set the share’s price value over the next 12 months at a high of $47.00 and a low of $47.00. But a downside of -23.96% will see the stock hit the forecast high price target while median target price for the stock is $47.00.
Insiders at the company have transacted a total of 30 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, accounting for 43,052 shares. Insider sales of the common stock occurred on 14 occasions, with total insider shares sold totaling 15,801 shares.
The top 3 mutual fund holders in National HealthCare Corporation are Invesco High Yield Equity Dividen, Vanguard Total Stock Market Index, and Vanguard Small Cap Index Fund. Invesco High Yield Equity Dividen owns 0.45 million shares of the company’s stock, all valued at over $26.94 million. The company bought an additional 793.0 shares recently to bring their total holdings to about 2.95% of the shares outstanding. Vanguard Total Stock Market Index bought 1990.0 shares to see its total holdings expand to 0.41 million shares valued at over $24.4 million and representing 2.67% of the shares outstanding. Vanguard Small Cap Index Fund sold 23967.0 shares to bring its total holdings to over 0.34 million shares at a value of $20.0 million. Vanguard Small Cap Index Fund now owns shares totaling to 2.19% of the shares outstanding.
Shares of National HealthCare Corporation (AMEX: NHC) opened at $58.64, down -$0.06 from a prior closing price of $58.70. However, the script later moved the day high at 58.80, down -0.75%. The company’s stock has a 5-day price change of 1.30% and -1.00% over the past three months. NHC shares are trading -2.08% year to date (YTD), with the 12-month market performance down to -11.01% lower. It has a 12-month low price of $55.31 and touched a high of $75.35 over the same period. NHC has an average intraday trading volume of 45.27K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.51%, -2.13%, and -11.72% respectively.
Institutional ownership of National HealthCare Corporation (AMEX: NHC) shares accounts for 46.40% of the company’s 15.45M shares outstanding. Mutual fund holders own 29.36%, while other institutional holders and individual stakeholders account for 31.41% and 14.41% respectively.
It has a market capitalization of $892.54M and a beta (3y monthly) value of 0.30. The stock’s trailing 12-month PE ratio is 28.23, while the earnings-per-share (ttm) stands at $2.06. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.72% over the week and 2.14% over the month.
The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0.
Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the NHC, a number of firms have released research notes about the stock. Morgan Keegan stated their Mkt Perform rating for the stock in a research note on August 01, 2011, with the firm’s price target at $55-$41.